Whats Going on Out There
Whats Going on Out There –
Orexo Announces the Launch of Abstral® in Japan
The company is commercializing its proprietary product, Zubsolv®, for maintenance treatment of opioid dependence, in the United States. Zubsolv is a novel formulation of buprenorphine and naloxone using Orexo's extensive knowledge in sublingual …
Read more on Business Wire (press release)
Vietnam urges more methadone treatment for people who use drugs
Methadone is just one “treatment door” among many others, including buprenorphine and naltrexone, which are wide open to drug users. Each is suitable for the affected communities depending upon their country's socio-economic conditions. But all of them …
Read more on Weekly Blitz
Orexo announces a new MSEK 200 credit facility
The company is commercializing its proprietary product, Zubsolv®, for maintenance treatment of opioid dependence, in the United States. Zubsolv is a novel formulation of buprenorphine and naloxone using Orexo's extensive knowledge in sublingual …
Read more on Business Wire (press release)
Find More Buprenorphine Treatment Information…